Skip to main content
  • Home
  • Sustainability
  • Articles
  • KitoZyme and Janssen PMP, a division of Janssen Pharmaceutica NV, sign an exclusive partnership
ARTICLE

KitoZyme and Janssen PMP, a division of Janssen Pharmaceutica NV, sign an exclusive partnership

08 May, 2023
  • •  Exclusive collaboration agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, to evaluate and develop KitoZyme's chitosan proprietary technology for post-harvest use on fresh produce.
  • •  Janssen PMP will fund and drive all testing and development work.

Herstal, Belgium – KitoZyme, the pioneer and global leader of high-quality fungal chitosan and Janssen PMP, a division of Janssen Pharmaceutica NV, have signed an Exclusive Collaboration Agreement to evaluate and develop KitoZyme technologies for post-harvest use on fresh produce. The agreement aims to evaluate and develop KitoZyme's cutting-edge technologies for post-harvest use on fresh produce, leveraging Janssen PMP's expertise and resources in this field. The collaboration is set to pave the way for innovative solutions to address food waste globally. KitoZyme has granted Janssen PMP the exclusive right to evaluate KitoZyme chitosan technologies for post-harvest storage preservation of fruits and vegetables globally.

The agreement aims to evaluate and develop KitoZyme's cutting-edge technologies for post-harvest use on fresh produce, leveraging Janssen PMP's expertise and resources in this field. The collaboration is set to pave the way for innovative solutions to address food waste globally. KitoZyme has granted Janssen PMP the exclusive right to evaluate KitoZyme chitosan technologies for post-harvest storage preservation of fruits and vegetables globally.

“Being able to control post-harvest pathogens and to extend fruits and vegetables shelf life with an effective natural compound such as KitoZyme’s chitosan is key in our development. This technology is the only chitosan produced from fungi already approved in Europe and USA for post-harvest use. Moreover, this technology is approved for Organic farming in some EU countries and is Vegan compliant”, said Geoffroy de Chabot-Tramecourt, Director R&D and Business Development at Janssen PMP.

“We are very excited to announce this partnership with Janssen PMP, a division of Janssen Pharmaceutica and a leader in its field. It fits very well with our vision to associate on a mutually exclusive basis our unique fungal sourced biopolymer into high value added applications.”, reacted François Blondel, CEO and Managing Director of KitoZyme.

About KitoZyme

KitoZyme S.A. (www.kitozyme.com and www.kitogreen-agri.com), founded in December 2000, is a pioneer and global leader of fungal chitosan manufacturing. Located in Herstal - Liège, Belgium, the company was established in order to capitalize on the great potential found in the field of fungal biopolymer extraction and offer safer and healthier alternative ingredients to remove or reduce petrochemicals, animal-derived, or toxic ingredients, in several sectors, namely agriculture, winemaking, and health and cosmetics.

For Contacts

Janssen PMP

Geoffroy de Chabot-Tramecourt

Director R&D and Business Development

Mobile: +32 471 80 82 09

Email: [email protected]

 

KITOZYME

François Blondel, CEO and Guillaume Deleixhe, Business Development Manager

Phone: +32 472 99 52 61

Email: [email protected]

Send an email to our experts